Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DPH Biologicals is a U.S.-based agricultural biologicals company that develops and commercializes biofertility, crop protection, seed treatment, and precision agronomy products for row crops, specialty crops, and turf and ornamental markets. The company is not a human healthcare, biotech, or pharma company; its focus is agricultural biological inputs built around microbes, plant extracts, algae, and related soil health technologies. Its commercial portfolio includes the TerraTrove biofertility line, the BellaTrove crop protection line, and newer platform technologies such as Prime and RegenAphex. DPH Biologicals markets products designed to improve soil structure, nutrient uptake, crop resilience, and suppression of soil-borne diseases. The company appears to be privately held, active, and management-owned since 2024, with strategic backing and a disclosed investment from Sumitomo.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DPH Biologicals.